Frequency Therapeutics

Release Summary

Frequency Therapeutics announces Chris Loose, Ph.D., the Company’s Co-founder and Chief Scientific Officer, will be presenting at the 14th Stem Cell Research and Regenerative Medicine Conference.

Frequency Therapeutics